Caregen Co.Ltd (KQ:214370) — Market Cap & Net Worth
Market Cap & Net Worth: Caregen Co.Ltd (214370)
Caregen Co.Ltd (KQ:214370) has a market capitalization of $768.08 Million (₩1.13 Trillion) as of May 2, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #10360 globally and #305 in its home market, demonstrating a 11.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Caregen Co.Ltd's stock price ₩105500.00 by its total outstanding shares 10743000 (10.74 Million). Analyse Caregen Co.Ltd cash conversion from operations to see how efficiently the company converts income to cash.
Caregen Co.Ltd Market Cap History: 2015 to 2026
Caregen Co.Ltd's market capitalization history from 2015 to 2026. Data shows growth from $117.99 Million to $768.08 Million (19.15% CAGR).
Index Memberships
Caregen Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$299.07 Billion | 0.26% | #78 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$299.07 Billion | 0.26% | #78 of 1384 |
Weight: Caregen Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Caregen Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Caregen Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Caregen Co.Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Caregen Co.Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $117.99 Million | $36.42 Billion | $19.25 Billion | 0.00x | 0.01x |
| 2016 | $98.91 Million | $46.84 Billion | $22.96 Billion | 0.00x | 0.00x |
| 2017 | $104.99 Million | $57.89 Billion | $24.29 Billion | 0.00x | 0.00x |
| 2018 | $87.49 Million | $51.21 Billion | $16.49 Billion | 0.00x | 0.01x |
| 2019 | $94.40 Million | $64.70 Billion | $28.07 Billion | 0.00x | 0.00x |
| 2020 | $95.75 Million | $60.30 Billion | $31.48 Billion | 0.00x | 0.00x |
| 2021 | $91.93 Million | $59.09 Billion | $25.32 Billion | 0.00x | 0.00x |
| 2022 | $193.75 Million | $69.10 Billion | $27.27 Billion | 0.00x | 0.01x |
| 2023 | $198.15 Million | $79.21 Billion | $39.93 Billion | 0.00x | 0.00x |
| 2024 | $209.67 Million | $82.59 Billion | $32.31 Billion | 0.00x | 0.01x |
Competitor Companies of 214370 by Market Capitalization
Companies near Caregen Co.Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Caregen Co.Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3165 globally with a market cap of $6.03 Billion USD ( ₩8.89 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #6412 globally with a market cap of $1.93 Billion USD ( ₩2.85 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #10928 globally with a market cap of $688.81 Million USD ( ₩1.02 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #12458 globally with a market cap of $507.93 Million USD ( ₩749.51 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3165 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $6.03 Billion | ₩415500.00 |
| #6412 | ST Pharm Co.Ltd | KQ:237690 | $1.93 Billion | ₩152500.00 |
| #10928 | NatureCell Co.Ltd | KQ:007390 | $688.81 Million | ₩19150.00 |
| #12458 | Mezzion Pharma Co.Ltd | KQ:140410 | $507.93 Million | ₩87700.00 |
Caregen Co.Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Caregen Co.Ltd's market cap moved from $117.99 Million to $ 768.08 Million, with a yearly change of 19.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩768.08 Million | +46.94% |
| 2025 | ₩522.73 Million | +149.31% |
| 2024 | ₩209.67 Million | +5.82% |
| 2023 | ₩198.15 Million | +2.27% |
| 2022 | ₩193.75 Million | +110.75% |
| 2021 | ₩91.93 Million | -3.99% |
| 2020 | ₩95.75 Million | +1.43% |
| 2019 | ₩94.40 Million | +7.90% |
| 2018 | ₩87.49 Million | -16.66% |
| 2017 | ₩104.99 Million | +6.15% |
| 2016 | ₩98.91 Million | -16.18% |
| 2015 | ₩117.99 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Caregen Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $768.08 Million USD |
| MoneyControl | $768.08 Million USD |
| MarketWatch | $768.08 Million USD |
| marketcap.company | $768.08 Million USD |
| Reuters | $768.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Caregen Co.Ltd
Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands. It also provides medical devices under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG S… Read more